718 PREEMPTIVE ANTIVIRAL THERAPY CAN REDUCE OVERALL TREATMENT-RELATED HEPATIC MORBIDITY AS WELL AS VIRAL REACTIVATION DURING TRANSARTERIAL CHEMO-EMBOLIZATION

Clicks: 236
ID: 273391
2011
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #19 of 20 articles by views in journal of hepatology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
jung2011journal718 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors S.H. Yoo,J.W. Jang,B.S. Oh,J.H. Kwon,C.D. Lee,K.W. Chung,H.S. Jung;S.H. Yoo;J.W. Jang;B.S. Oh;J.H. Kwon;C.D. Lee;K.W. Chung;H.S. Jung;
Journal journal of hepatology
Year 2011
DOI
10.1016/s0168-8278(11)60720-4
URL
https://sciprofiles.com/publication/view/e63843fd5777ae5bb9b6a42480a3cccf
Keywords
antiviral therapy viral reactivation preemptive antiviral chemo embolization treatment related transarterial chemo hepatic morbidity

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.